Human CD40 / CD40 Ligand Inhibitor Screening Kit (TR-FRET)

Customer Reviews
Cat. No. / Size
Price
Qty
ETA of in-stock products:3 business days

Product Details

  • FAB

    1. Simple and fast operation - No complicated washing steps, significantly reducing time.
    2. High batch consistency - Strict control over raw materials and finished product quality, ensuring a stable supply.
    3. Accurate and reliable results - High sensitivity with minimal matrix effects.
    4. High throughput capability - Support multiple product specifications, ideal for high-throughput screening.
    5. Fast completion - Results in just 1 hour.
  • Product Specifications

    Assay Type
    Competition-TR-FRET
    Reactivity
    Human
    Regulatory Status
    RUO
    Assay Time
    1 hr
    Sample volume
    10 μL

  • Product Overview

    The Human CD40 / CD40 Ligand Inhibitor Screening Kit (TR-FRET) is based on a homogeneous (no wash) competitive TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screen for inhibitors of human CD40 binding to CD40 Ligand within 0.5-1 hours. It can also be used as a universal detection tool to identify the ability of human CD40 to bind to human CD40 Ligand.

  • Storage

    1. Store the unopened kit at 2-8°C upon receipt.

    2. Locate the expiration date on the outer packaging and do not use reagents beyond their expiration date.

    3. The opened kit should be stored according to the storage conditions listed in the Components Table. The shelf life of the opened kit is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    FRTP018-C01
    Human CD40 Ligand Europium-chelate
    100 tests/500 tests
    FRTP018-C02
    FA Labeled Human CD40 Protein
    100 tests/500 tests
    FRTP018-C03
    Anti-CD40 Neutralizing Antibody
    30 μg/100 tests 150 μg/500 tests
    DB-04
    TR-FRET Sample Dilution Buffer, pH7.4
    50 mL/100 tests & 500 tests
    DB-05
    TR-FRET Detection Buffer, pH7.4
    50 mL/100 tests & 500 tests

  • Assay Principles

    This Human CD40 / CD40 Ligand Inhibitor Screening Kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). This assay uses the mixture of biotinylated human CD40 Ligand and Europium-chelate labeled streptavidin as the Donor and FA Labeled Human CD40 Protein as the Acceptor.

    — When the sample does not contain the inhibitors that block the binding of human CD40 Ligand to human CD40, the Donor and Acceptor are in close proximity because of the binding of human CD40 Ligand and human CD40. Upon Donor excitation with light of a specific wavelength (337nm), in addition to Donor emission (620nm), non-radiative transfer of energy occurs between Donor and Acceptor, resulting in Acceptor emission (665nm).

    — When the sample contains the inhibitors that block the binding of human CD40 Ligand to human CD40, the components inhibit the binding between the Donor and Acceptor and thereby prevent FRET from occurring.

    Assay Principles
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-TR-FRET 

    Please refer to DS document for the assay protocol.

     CD40 / CD40 Ligand TR-FRET

    In this TR-FRET assay, Human CD40 Ligand Europium-chelate is used as the Donor and FA Labeled Human CD40 Protein is used as the Acceptor. An inhibition Assay was performed to evaluate the interaction between human CD40 Ligand and human CD40 using Anti-CD40 Neutralizing Antibody resulting in a typical IC50 of 8.509 nM (QC tested).

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews